The following books authored by LIMR researchers have been published in recent years:
Cardiac Arrhythmias, Pacing and Sudden Death (Cardiovascular Medicine)
Peter Kowey, MD, LIMR professor and world-renowned cardiologist at Lankenau Heart Institute in Lankenau Medical Center, co-authored the textbook “Cardiac Arrhythmias, Pacing and Sudden Death” (Springer, 2017), which provides up-to-date, user-friendly and comprehensive guidance on the evaluation, diagnosis, and medical and surgical treatment of cardiac arrhythmias. The book aids every trainee and practicing cardiologist, cardiac electrophysiologist, cardiac surgeon, vascular surgeon, and physician who manages cardiac patients.
Sunil Thomas, PhD, a research assistant professor who specializes in immunology at the LIMR, wrote “Rickettsiales: Biology, Molecular Biology, Epidemiology, and Vaccine Development” (Springer, 2017), the first comprehensive book that covers every genera of the order Rickettsiales, small proteobacteria that are known to cause diseases in humans and animals.
Preserving the Promise: Improving the Culture of Biotech Investment
For anyone who has ever wondered why—with so much focus and funds flowing into the biotechnology arena — there are relatively few extraordinary breakthroughs realized, a book co-authored by LIMR’s Scott Dessain, MD, PhD, can shed light on the challenges. In their book “Preserving the Promise: Improving the Culture of Biotech Investment” (Academic Press, 2016), the authors also point the way to strategies that, if adopted, could improve the chances of more life-saving (and affordable) therapies transitioning from the laboratory to the clinic.
J Wave Syndromes: Brugada and Early Repolarization Syndromes
“(Springer, 2016) Edited by LIMR Professors Charles Antzelevitch and Gan-Xin Yan delineates the state of the art of the diagnosis and treatment of J wave syndromes, as well as where future research needs should be directed. It covers basic science, translational and clinical aspects of these syndromes. The authors are leading experts in their respective fields, who have contributed prominently to the literature concerning these topics.
Vaccine Design - Methods and Protocols: Volume 1: Vaccines for Human Diseases
This text provides a practical step-by-step protocol to design and develop vaccines. Chapters detail protocols for developing novel vaccines against infectious bacteria, viruses, fungi, and parasites for humans and animals. “Vaccines for Human Diseases, Vol. 1” (Humana Press, 2016) has an introductory section on how vaccines impacted diseases, the immunological mechanism of vaccines, future challenges for vaccinologists, and current trends in vaccinology. The design of human vaccines for viral, bacterial, fungal, parasitic and prion diseases, as well as vaccines for drug abuse, allergy, and tumor vaccines, are also described in this volume.
Vaccine Design - Methods and Protocols, Volume 2: Vaccines for Veterinary Diseases
This text provides step-by-step protocol to design and develop vaccines. Chapters detail protocols for developing novel vaccines against infectious bacteria, viruses, fungi, and parasites. “Vaccines for Veterinary Diseases, Vol. 2” (Humana Press, 2016) includes vaccines for farm animals and fishes, vaccine vectors and production, vaccine delivery systems, vaccine bioinformatics, vaccine regulation and intellectual property.
Cancer Immunotherapy: Immune Suppression and Tumor Growth, 2nd Ed.
This book, co-edited by LIMR President and CEO George Prendergast, PhD, highlights emerging new principles of immune suppression that drive cancer, and it offers new ideas about how therapy can be improved by attacking these principles (Academic Press, 2013).
Rybakovsky E, Buleza NB, Hoxha K, DiGuilio KM, McCluskey ES, Friday CL, Callaghan PJ, Moskalenko DV, Zuo B, Thomas S, Mullin JM. Spontaneous and cytokine-induced hole formation in epithelial cell layers: Implications for barrier function studies with the gingival cell culture, Gie-3B11, and other epithelial models. Trends in Cell & Molecular Biology. 2018 13:99-114.
Michowitz Y, Milman A, Andorin A … Yan GX, et al. Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome. J Am Coll Cardiol. 2019 73(14):1756-65.
Perino AC, Shrader P … Kowey PR, et al. Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT-AF Registry. J Am Heart Assoc. 2019 8(9):e011205.
Vemulapalli S, Inohara T, Kim S … Ezekowitz M, Kowey PR, et al. Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry). The American Journal of Cardiology 2019 123(10):1628–36.
Manley K, Bravo-Nuevo A, Minton AR, Sedano S, Marcy A, Reichman M, Tobia A, Artlett CM, Gilmour SK, Laury-Kleintop LD, Prendergast GC. Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine. J Cell Biochem. 2019 Feb 27.
Madhavan M, Holmes DN, Piccini JP, … Kowey PR, et al. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 Jan 30;211:77-89.
Puligedda RD, Sharma R, Al-Saleem FH, Kouiavskaia D, Velu AB, Kattala CD, Prendergast GC, Lynch DR, Chumakov K, Dessain SK. Capture and display of antibodies secreted by hybridoma cells enables fluorescent on-cell screening. MAbs. 2019 Feb 22:1-13.
Li X, Sacher F, Kusano KF, Barajas-Martinez H, … Antzelevitch C, et al. Pooled Analysis of Risk Stratification of Spontaneous Type 1 Brugada ECG: Focus on the Influence of Gender and EPS. Front Physiol. 2019 Jan 31;9:1951.
Lemos H, Huang L, Prendergast GC, Mellor AL. Immune control by amino acid catabolism during tumorigenesis and therapy. Nat Rev Cancer. 2019 Mar;19(3):162-175. Review.
Andrew RJ, De Rossi P, … Laury-Kleintop L, et al. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model. J Biol Chem. 2019 Jan 28. doi: 10.1074/jbc.RA118.006379.
Chen CJ, Lu TP, … Antzelevitch C. Impact of Ancestral Differences and Reassessment of the Classification of Previously Reported Pathogenic Variants in Patients With Brugada Syndrome in the Genomic Era: A SADS-TW BrS Registry. Front Genet. 2019 Jan 4;9:680.
Almonte-Baldonado R, Bravo-Nuevo A, Gerald D, Benjamin LE, Prendergast GC, Laury-Kleintop LD. RhoB antibody alters retinal vascularization in models of murine retinopathy.J Cell Biochem. 2018 Dec 9. doi: 10.1002/jcb.28213.
Winters M, DuHadaway JB, … Prendergast GC, Muller AJ, Malachowski WP. Diaryl hydroxylamines as pan or dual inhibitors of IDO1, IDO2 and tryptophan dioxygenase. Eur J Med Chem. 2018 Nov 14;162:455-64.
Sicouri S, Antzelevitch C. Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest. Arrhythm Electrophysiol Rev. 2018 Aug;7(3):199-209.
Bhattacharya P, Dessain SK, Evans TL. Palliative Care in Lung Cancer: When to Start. Curr Oncol Rep. 2018 Nov 9;20(11):90. Review.
Yoon N, Patocskai B, Antzelevitch C. Epicardial Substrate as a Target for Radiofrequency Ablation in an Experimental Model of Early Repolarization Syndrome. Circ Arrhythm Electrophysiol. 2018 Sep;11(9).
Sicouri S, Belardinelli L, Antzelevitch C. Effect of autonomic influences to induce triggered activity in muscular sleeves extending into the coronary sinus of the canine heart and its suppression by ranolazine. J Cardiovasc Electrophysiol. 2018 Oct 9.
Nevler A, Muller AJ, Sutanto-Ward E, DuHadaway JB, Nagatomo K, … Mandik-Nayak L, Winter JM, Yeo CJ, Prendergast GC, Brody JR. Host IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancers. Clin Cancer Res. 2018 Sep 28.
Thomas S, … Prendergast GC, Mullin JM. Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis. J Cell Biochem. 2018 Sep 30.
Fox E, Oliver T, Rowe M, Thomas S, Zakharia Y, Gilman PB, Muller AJ, Prendergast GC. Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer. Front Oncol. 2018 Sep 11;8:370.
Thind M, Holmes DN, Badri M, Kowey PR, … et al. Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry). Am J Cardiol. 2018 Aug 20.
Muller AJ, Manfredi MG, Zakharia Y, Prendergast GC. Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond. Semin Immunopathol. 2018 Sep 10.
Castro Hevia J, Dorantes Sanchez M, … Antzelevitch C, et. al. Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome. Int J Cardiol. 2018 Aug 30.
Burashnikov A, Antzelevitch C. Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden? Pacing Clin Electrophysiol. 2018 Aug 27.
Qi D, Gao Y, Yan GX. Electrocardiographic J wave: Early repolarization, Brugada wave, and conduction delay. Heart Rhythm. 2018 Aug 14.
McTigue KM, Hartelius EJ, Anderson TS, … Larson SL, et al. Using a deliberative forum for engaging health system and health plan leaders to prioritize research topics. 2018; 6(2).
Sharma R, Al-Saleem FH, Panzer J, ... Cox RH, Dessain SK. Monoclonal antibodies from a patient with anti-NMDA receptor encephalitis. Annals of Clinical and Translational Neurology. 2018 Jul 5.
Sharma R, Al-Saleem FH, Puligedda RD, Rattelle A, Lynch DR, Dessain SK. Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis. BMC Biotechnol. 2018 Jun 27;18(1):41.
Camm JA, Dorian P, Hohnloser SH, Kowey PR, et al. A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2018 Jul 23;11(14):1401-10.
Jackson LR 2nd, Kim S, Shrader P, Blanco R, Thomas L, Ezekowitz MD, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, et al. Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. J Thromb Thrombolysis. 2018 Jul 26, pp1-5.
Argenziano M, Antzelevitch C. Recent advances in the treatment of Brugada syndrome. Expert Rev Cardiovasc Ther. 2018 Jun;16(6):387-404.
Turner JR, Rodriguez I, Mantovani E, Gintant G, Kowey PR, et al. Drug‐induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy. J Clin Pharmacol 2018 April 19.
Kowey PR, Fudim M, Liu PR, Shrader P, et al. Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF Registry. J Am Heart Assoc. Apr 13, 2018;7(8).
Yan GX, Tse G, Wong CW, et al. Meta-analysis of T-wave indices for risk stratification in myocardial infarction. International Health Informatics Study (IHIS) Network. J Geriatr Cardiol. 2017 Dec;14(12):776-779.
Prendergast GC, Mondal A, Dey S, Laury-Kleintop LD, Muller AJ. Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'. Trends Cancer. 2018 Jan;4(1):38-58.
Nevler A, Muller AJ, Cozzitorto JA, Goetz A, Winter JM, Yeo TP, Lavu H, Yeo CJ, Prendergast GC, Brody JR. A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2. J Am Coll Surg. 2018 Feb 7. doi.org/10.1016/j.jamcollsurg.2017.12.052.
Peters MC, Minton A, Phanstiel Iv O, Gilmour SK. A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors. Med Sci (Basel). 2018 Jan 5;6(1). pii: E3.
Prendergast GC, Malachowski WJ, Mondal A, Scherle P, Muller AJ. Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer. Int Rev Cell Mol Biol. 2018;336:175-203.
DiGuilio KM, Valenzano MC, Rybakovsky E, Mullin JM. Cobalt chloride compromises transepithelial barrier properties of CaCo-2 BBe human gastrointestinal epithelial cell layers. BMC Gastroenterol. 2018 Jan 5;18(1):2.